TERT-BUTYL 3-((TERT-BUTOXYCARBONYLOXY)METHYL)-1H-INDOLE-1-CARBOXYLATE, 95.0%, 250mg

Formic Acid300mL

2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-, 98%, 500mg

METHYL 2-AMINO-4-CHLORO-5-METHOXYBENZOATE, 95.0%, 250mg

Hyperoside, ROTICHROM® TLC, 100 mg, envase de vidrio

cis-ethyl (1R,2S)-2-cyanocyclopropane-1-carboxylate, 95.0%, 1g

Bidón tipo 2320, con conexión para llave de paso, 9 l, 1 unidad

4-(2-Hydroxyphenyl)-2-(4-pyridyl)thiazole, 1g

{[(3-chlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 2g

2-Amino-3-methylnaphthalene-1,4-dione, 98%, 1g

3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propan-1-amine, 97%, 50mg

3-Chloro-4-iodobenzoic acid, 96.0%, 1g

Dimethyl-1,2-thiazole-4-carboxylic acid, 95%, 250mg